CMTS0929 for C. diff infection
Part of Infections clinical trials.
This trial tests a new treatment called CMTS0929 for people with C. diff infection. It aims to see if the treatment can help clear the infection and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a confirmed C. diff infection (positive lab test or colonoscopy findings).
- You currently have diarrhea (at least 3 loose bowel movements a day for 2 days or more).
- Your immune system is not weakened (for example, no HIV, low white blood cells, or use of steroids or immune-suppressing drugs).
- You do not have any other infections besides C. diff.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called washed microbiota transplantation (WMT) for people with a C. diff infection that causes diarrhea. WMT uses processed donor bacteria to help restore healthy gut balance and fight the infection.
This study is tracking patients with a confirmed C. difficile infection to understand how the body responds and how treatments work. You may be asked to do follow-up visits for up to 5 years.
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
This study tests whether the supplement alanyl-glutamine, given along with standard treatment, can improve outcomes for adults being treated for C. difficile infection (a cause of diarrhea). It may help the body recover better after antibiotics that usually treat C. difficile.
This trial compares three treatments for Clostridioides difficile infection (a severe diarrhea caused by bacteria) to see which works best and prevents it from coming back. It tests a fecal microbiota transplant (FMT, transferring healthy donor stool), fidaxomicin, and vancomycin, all given by mouth or tube.
This study tests if a freeze-dried fecal transplant (FMT) can help people with difficult-to-treat diarrhea caused by IBS-D or recurring C. diff infections. It's a way to restore healthy gut bacteria and may reduce symptoms.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.